Pharmaceutical Impurities
Pharmaceutical Impurities(医药杂质)
Pharmaceutical Impurities 相关产品(35)
- GC49683N-desethyl-N-methyl VardenafilCAS: 224785-87-9纯度: >95.00%
A potential impurity found in commercial preparations of vardenafil
- GC49690(3R,5R)-Rosuvastatin (calcium salt)CAS: 1422515-55-6纯度: >95.00%
A potential impurity found in bulk preparations of rosuvastatin
- GC62026Devaleryl Valsartan ImpurityCAS: 676129-92-3纯度: >99.50%
A potential impurity found in commercial preparations of valsartan
- GC913655-(4'-(Azidomethyl)(1,1'-biphenyl)-2-yl)-2H-tetrazoleCAS: 152708-24-2纯度: >95.00%
5-(4'-(偶氮甲基)(1,1'-联苯)-2-基)-2H-四唑（AZTT）是一种可能存在于商业制备的含有四唑类Sartan药物中，包括洛卡新、厄贝沙坦和缬沙坦等药物中的杂质。
- GC91450De-Boc-CabazitaxelCAS: 1638286-64-2纯度: >95.00%
De-Boc-Cabazitaxel是半合成紫杉醇cabazitaxel商业制剂中的潜在杂质。它还被用于合成针对微管靶向荧光染料。
- GC91548Rosuvastatin EP Impurity A (calcium salt)CAS: 1714147-47-3纯度: >98.00%
Rosuvastatin EP impurity A is a potential impurity in commercial preparations of the HMG-CoA reductase inhibitor rosuvastatin.
- GC91669m-isobutyl IbuprofenCAS: 66622-47-7纯度: >98.00%
m-isobutyl Ibuprofen is a potential impurity in commercial preparations of the non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor ibuprofen.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49683 | N-desethyl-N-methyl Vardenafil | 224785-87-9 | >95.00% | |
A potential impurity found in commercial preparations of vardenafil | ||||
| GC49690 | (3R,5R)-Rosuvastatin (calcium salt) | 1422515-55-6 | >95.00% | |
A potential impurity found in bulk preparations of rosuvastatin | ||||
| GC62026 | Devaleryl Valsartan Impurity | 676129-92-3 | >99.50% | |
A potential impurity found in commercial preparations of valsartan | ||||
| GC90480 | Safinamide Metabolite NW 1689 | 405-85-6 | >95.00% | |
商业制备的沙非胺中发现了潜在杂质。 | ||||
| GC90517 | 2,2'-Bisnaloxone | 211738-08-8 | >95.00% | |
商业制备的纳洛酮中可能存在杂质。 | ||||
| GC91212 | SM-102 N-oxide | 2824195-50-6 | >98.00% | |
商业制备的SM-102中可能存在杂质。 | ||||
| GC91365 | 5-(4'-(Azidomethyl)(1,1'-biphenyl)-2-yl)-2H-tetrazole | 152708-24-2 | >95.00% | |
5-(4'-(偶氮甲基)(1,1'-联苯)-2-基)-2H-四唑（AZTT）是一种可能存在于商业制备的含有四唑类Sartan药物中，包括洛卡新、厄贝沙坦和缬沙坦等药物中的杂质。 | ||||
| GC91450 | De-Boc-Cabazitaxel | 1638286-64-2 | >95.00% | |
De-Boc-Cabazitaxel是半合成紫杉醇cabazitaxel商业制剂中的潜在杂质。它还被用于合成针对微管靶向荧光染料。 | ||||
| GC91453 | ALC-0315 N-oxide | - | >98.00% | |
商业制备的可离子化阳离子氨基脂质ALC-0315中可能存在一种潜在杂质ALC-0315 N-oxide。 | ||||
| GC91548 | Rosuvastatin EP Impurity A (calcium salt) | 1714147-47-3 | >98.00% | |
Rosuvastatin EP impurity A is a potential impurity in commercial preparations of the HMG-CoA reductase inhibitor rosuvastatin. | ||||
| GC91669 | m-isobutyl Ibuprofen | 66622-47-7 | >98.00% | |
m-isobutyl Ibuprofen is a potential impurity in commercial preparations of the non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor ibuprofen. | ||||